← Back
$KURA All transactions

Kura Oncology, Inc.

A

$ Value

$0

Shares

21,250

Price

$0

Filed

Jan 6

Insider

Name

DOYLE THOMAS JAMES

Title

SVP, Finance & Accounting

CIK

0001910331

Roles

Officer

Transaction Details

Transaction Date

2026-01-02

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

152,309

Footnotes

Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/27, 1/26/28, 1/26/29 and 1/26/30. | Includes 802 shares acquired on November 17, 2025 pursuant to the Issuer's Employee Stock Purchase Plan. | This option vests in 48 equal monthly installments commencing on the grant date.

Filing Info

Accession No.

0001193125-26-004569

Form Type

4

Issuer CIK

0001422143

DOYLE THOMAS JAMES's History

Date Ticker Type Value
2026-01-27 KURA $19K
2026-01-27 KURA $9K
2026-01-27 KURA $6K
2026-01-27 KURA $19K
2026-01-27 KURA $7K
2026-01-02 KURA A $0
2026-01-02 KURA A $0
2025-11-14 KURA $51K
2025-11-13 KURA A $0
2025-09-29 KURA $41K

Other Insiders at KURA (90d)

Insider Bought Sold Last
WILSON TROY EDWARD
President and CEO
2026-03-23
FORD KATHLEEN
Chief Operating Officer
$15K 2026-01-27
Bair Teresa Brophy
Chief Legal Officer
$95K 2026-01-27
DOYLE THOMAS JAMES
SVP, Finance & Accounting
$60K 2026-01-27
Powl Brian T.
Chief Commercial Officer
$54K 2026-01-27
Leoni Mollie
Chief Medical Officer
$69K 2026-01-27
Burrows Francis
Chief Scientific Officer
$11K 2026-01-27